Abbott Laboratories is seeking to enforce its patent rights
relating to fenofibrate tablets, according to the Company’s latest
Quarterly Report filed with the U.S. Securities and Exchange
Commission on May…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.